Non-Invasive Biomarkers of NASH

Non-Invasive Biomarkers of NASH

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH).  Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022. This browser does not support PDFs. Please download the PDF to view it: Download PDF.

STUDIES ARE ENROLLING NOW!

Medical

Apply to participate in a study for Diabetes, Obesity, Cardiac, Fatty Liver, Kidney, or Liver

Hernia

If you are suffering from hernia pain you may qualify for a clinical trial. Find out how to get involved today.

Bunions

Bunions can be painful and annoying. Find out if you qualify for a clinical trial enrolling now.